Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $383722.0.

  • Iradimed's Depreciation & Amortization (CF) rose 9421.98% to $383722.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $980186.0, marking a year-over-year increase of 1835.64%. This contributed to the annual value of $817656.0 for FY2024, which is 685.8% up from last year.
  • Per Iradimed's latest filing, its Depreciation & Amortization (CF) stood at $383722.0 for Q3 2025, which was up 9421.98% from $207476.0 recorded in Q2 2025.
  • Over the past 5 years, Iradimed's Depreciation & Amortization (CF) peaked at $494176.0 during Q2 2022, and registered a low of -$692905.0 during Q4 2022.
  • For the 5-year period, Iradimed's Depreciation & Amortization (CF) averaged around $233981.7, with its median value being $207476.0 (2025).
  • Per our database at Business Quant, Iradimed's Depreciation & Amortization (CF) plummeted by 27923.05% in 2022 and then surged by 12963.97% in 2023.
  • Quarter analysis of 5 years shows Iradimed's Depreciation & Amortization (CF) stood at $386600.0 in 2021, then tumbled by 279.23% to -$692905.0 in 2022, then soared by 129.64% to $205375.0 in 2023, then dropped by 5.12% to $194866.0 in 2024, then surged by 96.92% to $383722.0 in 2025.
  • Its last three reported values are $383722.0 in Q3 2025, $207476.0 for Q2 2025, and $194122.0 during Q1 2025.